Australia markets closed

Caribou Biosciences, Inc. (CRBU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7700+0.1300 (+3.57%)
At close: 04:00PM EDT
3.7000 -0.07 (-1.86%)
After hours: 07:09PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 340.50M
Enterprise value 38.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.07
Price/book (mrq)0.92
Enterprise value/revenue 1.12
Enterprise value/EBITDA -0.34

Trading information

Stock price history

Beta (5Y monthly) 2.47
52-week change 3-15.35%
S&P500 52-week change 322.38%
52-week high 38.5900
52-week low 33.4400
50-day moving average 35.3027
200-day moving average 35.5317

Share statistics

Avg vol (3-month) 31.6M
Avg vol (10-day) 31.48M
Shares outstanding 590.32M
Implied shares outstanding 690.32M
Float 868.44M
% held by insiders 110.14%
% held by institutions 178.10%
Shares short (15 Apr 2024) 411.34M
Short ratio (15 Apr 2024) 46.71
Short % of float (15 Apr 2024) 413.16%
Short % of shares outstanding (15 Apr 2024) 412.56%
Shares short (prior month 15 Mar 2024) 410.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -296.05%
Operating margin (ttm)-1,052.33%

Management effectiveness

Return on assets (ttm)-18.00%
Return on equity (ttm)-30.50%

Income statement

Revenue (ttm)34.48M
Revenue per share (ttm)0.47
Quarterly revenue growth (yoy)-3.60%
Gross profit (ttm)N/A
EBITDA -112.53M
Net income avi to common (ttm)-102.07M
Diluted EPS (ttm)-1.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)328.83M
Total cash per share (mrq)3.64
Total debt (mrq)27.11M
Total debt/equity (mrq)7.36%
Current ratio (mrq)11.97
Book value per share (mrq)4.16

Cash flow statement

Operating cash flow (ttm)-93.29M
Levered free cash flow (ttm)-64.36M